Related Experiment Videos
Routine prenatal screening revisited.
1Abyad Medical Center, Tripoli, Lebanon. amc@inco-tr.com.lb
Health Care for Women International
|July 20, 1999
Summary
Routine hematocrit screening during prenatal checkups may not be necessary for all pregnant women. High-risk individuals, including young mothers and those with increased parity, benefit most from targeted anemia screening and iron supplementation.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Public Health
Background:
- Routine obstetric screening is crucial for maternal health.
- Hematocrit levels are a key indicator of anemia during pregnancy.
- Previous studies highlight the importance of prenatal care and anemia detection.
Purpose of the Study:
- To evaluate the value of routine hematocrit screening in prenatal care.
- To identify risk factors for anemia in pregnant women.
- To inform recommendations for iron supplementation and screening protocols.
Main Methods:
- Retrospective chart review of pregnant women at the American University of Beirut Family Medicine Practice Center.
- Collection of demographic data and hematocrit values over an eight-year period.
- Statistical analysis to determine the prevalence of anemia and associated risk factors.
Main Results:
- The mean hematocrit value was 35.87, with a 7% prevalence of anemia.
- Anemia risk was highest in the 15-19 age group and increased with parity.
- 17% of women reported iron intake, which was statistically significant in anemic patients.
Conclusions:
- Routine hematocrit screening for all pregnant women warrants reevaluation.
- Targeted screening for high-risk patients is recommended.
- Increased critical consideration of iron supplementation is necessary for pregnant women.